Endothelial nitric oxide synthase is essential for the HMG‐CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia
Open Access
- 17 September 2001
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 15 (13) , 2530-2532
- https://doi.org/10.1096/fj.01-0415fje
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Randomized, Single-Blind, Placebo-Controlled Pilot Study of Catheter-Based Myocardial Gene Transfer for Therapeutic Angiogenesis Using Left Ventricular Electromechanical Mapping in Patients With Chronic Myocardial IschemiaCirculation, 2001
- Therapeutic Angiogenesis for Ischemic Cardiovascular DiseaseJournal of Molecular and Cellular Cardiology, 2001
- Left Ventricular Electromechanical Mapping to Assess Efficacy of phVEGF 165 Gene Transfer for Therapeutic Angiogenesis in Chronic Myocardial IschemiaCirculation, 2000
- VEGF Gene Delivery to MyocardiumCirculation, 2000
- Current Perspectives on StatinsCirculation, 2000
- Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1Science, 1999
- Cancer and AtherosclerosisCirculation, 1999
- Gene Therapy for Myocardial AngiogenesisCirculation, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Clinical Applications of Research on AngiogenesisNew England Journal of Medicine, 1995